Exact pathophysiology of PN is currently not understood. Based on the evolving literature, type 2 inflammation may play a role in PN.

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.

Many associated factors are modifiable indicating potential benefit from planned strategies.

Low anti-Factor Xa indicative of inadequate enoxaparin dosing is associated with a higher incidence of post-surgical Venous Thromboembolism.